A Prospective, Randomized, Double-blind, Placebo Controlled, Multi-national Study of Therapeutic Anticoagulation Strategy for Acute Chest Syndrome in Adults
Phase of Trial: Phase III
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms TASC
- 18 Oct 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2018.
- 18 Oct 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Dec 2018.
- 18 Oct 2017 Status changed from not yet recruiting to recruiting.